0001178913-18-002082.txt : 20180713 0001178913-18-002082.hdr.sgml : 20180713 20180713160847 ACCESSION NUMBER: 0001178913-18-002082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180713 FILED AS OF DATE: 20180713 DATE AS OF CHANGE: 20180713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hirsch Stanley CENTRAL INDEX KEY: 0001727864 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36621 FILM NUMBER: 18952616 MAIL ADDRESS: STREET 1: C/O FOAMIX PHARMACEUTICALS LTD. STREET 2: 2 HOLZMAN STREET, WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd. CENTRAL INDEX KEY: 0001606645 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 BUSINESS PHONE: 97289316233 MAIL ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 FORMER COMPANY: FORMER CONFORMED NAME: Foamix Ltd. DATE OF NAME CHANGE: 20140428 4 1 zk1821887.xml OWNERSHIP DOCUMENT X0306 4 2018-07-13 0 0001606645 Foamix Pharmaceuticals Ltd. FOMX 0001727864 Hirsch Stanley C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLTZMAN STREET REHOVOT L3 7670402 ISRAEL 1 0 0 0 Ordinary Shares 2018-07-13 4 M 0 1616 0.00 A 12974 D Restricted Share Units 0.00 2018-07-13 4 M 0 1616 0 D Ordinary Shares 1616 0 D This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer. The issuer's method of reporting restricted share units has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, this amount includes (i) 6,508 ordinary shares previously reported in Table I of the reporting person's Form 4 (ii) 1,616 ordinary shares underlying restricted share units that vested on July 13, 2018 (iii) 4,850 ordinary shares subject to unvested restricted share units that were previously reported in Table II of the reporting person's Form 3 as a derivative security. The ordinary shares underlying this restricted share unit award vest over a period of four years (25% on July 13, 2018 and 6.25% every three months thereafter) ending July 13, 2021. This class of restricted share units is included in Column 5 of Table I above. /s/ Ilan Hadar as attorney-in-fact for Stanley Hirsch 2018-07-13